机构：[1]Radiology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室医技科室放射科放射科首都医科大学附属天坛医院[2]Radiology Department, Beijing Neurosurgical Institute, Beijing, China重点科室医技科室研究所放射科放射科北京市神经外科研究所首都医科大学附属天坛医院[3]Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China[4]Interventional Neurology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院[5]Neurology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China重点科室诊疗科室神经病学中心神经病学中心首都医科大学附属天坛医院
Objective This study aimed to investigate the association between abnormal signs on susceptibility-weighted imaging (SWI) and post-treatment outcome in the early stage in patients with acute ischemic stroke. Methods Thirty-seven patients with middle cerebral artery territory infarction were recruited. Baseline and 24-hour follow-up magnetic resonance imaging was performed. Pre- and 24-hour post-treatment clinical conditions were assessed with the National Institutes of Health Stroke Scale (NIHSS) score. Prominent vessel sign (PVS) on SWI and infarcted areas on diffusion-weighted imaging (DWI) were assessed using the Alberta Stroke Program Early CT (ASPECT) score system. Susceptibility vessel sign (SVS) was evaluated and recorded. The associations between image abnormalities and clinical scores were analyzed. Results PVS was found in 35 patients and SVS in seven patients. The extent of PVS was significantly correlated with the post-treatment DWI ASPECT score (r=0.79), but not with the post-treatment NIHSS score or the post-pre NIHSS difference score. The presence of SVS was significantly correlated with the post-treatment NIHSS score (r=0.41). Conclusion PVS might be a useful predictor of early imaging prognosis and infarct growth in patients with acute ischemic stroke. SVS is related to a poor early outcome and could be useful for assessing stroke.
基金：
National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81301193, 81361120402]; Beijing Municipal Natural Science FoundationBeijing Natural Science Foundation [7133238, 7162056]
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2018]版：
大类|4 区医学
小类|4 区医学：研究与实验4 区药学
最新[2023]版：
大类|4 区医学
小类|4 区医学：研究与实验4 区药学
JCR分区：
出版当年[2017]版：
Q4PHARMACOLOGY & PHARMACYQ4MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版：
Q4MEDICINE, RESEARCH & EXPERIMENTALQ4PHARMACOLOGY & PHARMACY
第一作者机构：[1]Radiology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
通讯作者：
通讯机构：[1]Radiology Department, Beijing Tiantan Hospital, Capital Medical University, Beijing, China[2]Radiology Department, Beijing Neurosurgical Institute, Beijing, China[3]Beijing Key Laboratory of Magnetic Resonance Imaging and Brain Informatics, Beijing, China[*1]Radiology Department, Beijing Tiantan Hospital, No. 6 Tiantan Xili, Dongcheng District, Beijing, 100050, China.
推荐引用方式(GB/T 7714)：
Jia Liang,Peiyi Gao,Yan Lin,et al.Susceptibility-weighted imaging in post-treatment evaluation in the early stage in patients with acute ischemic stroke[J].JOURNAL OF INTERNATIONAL MEDICAL RESEARCH.2019,47(1):196-205.doi:10.1177/0300060518799019.
APA：
Jia Liang,Peiyi Gao,Yan Lin,Ligang Song,Haiqiang Qin&Binbin Sui.(2019).Susceptibility-weighted imaging in post-treatment evaluation in the early stage in patients with acute ischemic stroke.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH,47,(1)
MLA：
Jia Liang,et al."Susceptibility-weighted imaging in post-treatment evaluation in the early stage in patients with acute ischemic stroke".JOURNAL OF INTERNATIONAL MEDICAL RESEARCH 47..1(2019):196-205
